Index tracked: MSCI Switzerland IMI High Dividend Yield Index (Net Total Return)
TER
—+ trans. 0.04%
Fund size
—
Tracking difference
—not computable
🇮🇹 tax rate
—white list not published
Replication
Physical
Income
Accumulating
Launch 20 Mar 2025 · costs from the KID as of 26 Aug 2026
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 2 Sept 2026
The investment objective of the sub-fund is to replicate the price and return performance before costs of the MSCI Switzerland IMI High Dividend Yield Index (Net Total Return). This sub-fund invests in shares of companies that are included in the MSCI Switzerland IMI High Dividend Yield Index (Net Total Return) and in shares that are not represented in the MSCI Switzerland IMI High Dividend Yield Index (Net Total Return) but which have been announced to be included in the MSCI Switzerland IMI High Dividend Yield Index (Net Total Return) and other…
Performance since series start (in euro) — base 100
20 Mar 2025 → 8 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
High 111 (28 Jul 2026) · low 90 (9 Apr 2025) · last 104. Past performance is not indicative of future results.
The live sheet, always up to date rebalix.com/en/etf/CH1416135353 Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.